Back to search results

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Lung Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Zhenzhou Yang) · yangzz@cqmu.edu.cn

  • Guizhou Provincial People's Hospital, Guiyang, Guizhou, China

    Contact: Study coordinator (Yu Zhang) · skyline_zyu@163.com

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hunan, China

    Contact: Study coordinator (Rui Meng) · mengruivip@163.com

  • Sichuan Cancer Hospital, Chengdu, Sichuan, China

    Contact: Study coordinator (Qifeng Wang) · wangqifeng@scszlyy.org.cn

  • West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Jianxin Xue) · killercell@163.com · +86 189 8225 1798

  • Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

    Contact: Study coordinator (Daiyuan Ma) · mdylx@163.com
Study leads

  • You Lu, MD

    Principal Investigator

    West China Hospital

View source on ClinicalTrials.gov(opens in a new tab)